The Dissolution enhancement of Meloxicam tablets from the synergistic effect of hydrotropic and sublimating agent
DOI:
https://doi.org/10.25156/ptj.v11n2y2021.pp100-108Keywords:
Meloxicam, Solubility, Solid dispersion, Sublimation, camphorAbstract
Background and Objective: Drugs which fall into Class II of Biopharmaceutical Classification System suffer from poor aqueous solubility that limits the dissolution and oral bioavailability. The improvement of the dissolution rate of this class of drug is an important issue for enhancing their bioavailability and therapeutic efficacy. The objective of this study is to investigate the magnitude of enhancement of the dissolution rate of Class II drug “Meloxicam (MLX)” by using more than one solubility enhancement technique.
Methods: MLX-sodium benzoate solid dispersion at different ratios were prepared by kneading method to enhance the solubility, then MLX tablets were prepared by from solid dispersion mass and camphor as a sublimating agent in different concentrations. Compatibility of drug-excipients was studied using Fourier transforms infrared technique and the prepared tablets were evaluated for their physical properties and in vitro drug release behavior.
Results: The solubility of MLX was enhanced by 17-fold when it dispersed at 1:2 ratio with sodium benzoate. After 45 min a significant enhancement (P < 0.05) of the dissolution profile of F2, F3, and F4 tables was observed when compared with F1 tablets, that indicate the efficiency of solid dispersion in enhancing the dissolution of poor water soluble drugs, Moreover, after 5 min a significant change (P < 0.05) of the percentage drug release of F3 and F4 observed when they compared with F2 which result from the synergistic effect of the hydrotropic and sublimating agent to produce tablets with rapid disintegration and drug release. Conclusion: The dissolution studies indicate that sodium benzoate is an effective agent to enhance the percentage of drug release and the camphor is a valuable sublimating agent to achieve a rapid drug release and pharmacological action.
Keywords: Meloxicam, Solubility, Solid dispersion, Sublimation and camphor
Downloads
References
Al-Nima, A., M. Al-Kotaji and A. Khayrallah. 2014. Preparation and
evaluation of meloxicam solid dispersions by solvent evaporation
method. Int. Res. J. Pharm. 5(11): 838-845.
Ankita, D. and S. Yogesh. 2016. Solubility enhancement study of poorly absorbable. World J. Pharm. Res. 5(3): 933-964.
Anna, K., K. Kyriakos and N. Ioannis. 2018. Co-amorphous solid
dispersions for solubility and absorption improvement of drugs:
Composition, preparation, characterization and formulations for
oral delivery. Pharmaceutics. 10(3): e10030098.
Asaad, F., A. Sally and D. Ahmed. 2015. MCM-41 for meloxicam
dissolution improvement: In vitro release and in vivo
bioavailability studies. J. Braz. Chem. Soc. 26(7): 1367-1378.
Chauhan, Y. S. U. Kataria and A. Dashora. 2018. Formulation and
evaluation of floating tablet for indomethacin. J. Drug Deliv. Ther.
(4): 338-345.
Dhandapani, B., S. Eswara, N. Susrutha, S. Rama, R. Sonia,
T. S. Sarath, G. Seetharamanjaneyulu, R. C. Baboo. 2010.
Spectrophotometric estimation of meloxicam in bulk and
its pharmaceutical formulations. Int. J. Pharm. Sci. Res.
(4):217-221.
Dileep, K., K. Nagaraju, E. Chinna. 2012. Ormulation and evaluation
of immediate release tablets containing anti platelet drugs. Int.
Res. J. Pharm. Appl. Sci. 2(5): 170-179.
Hamsanandini, J., S. Parthiban, A. Vikneswari, G. P. Sentilkumar and
T. T. Mani. 2015. Formulation and evaluation of Orodispersible
liquisolid compacts of meloxicam using psyllium husk powder
as a natural superdisintegrants. Int. J. Res. Pharm. Nano Sci.
(2): 97-110.
Ibrahim, N. J., S. S. Smail, N. R. Hussein and T. A. Abdullah. 2020.
Solubility enhancement of nimodipine using mixed hydrotropic
solid dispersion technique. Zanco J. Med. Sci. 24(3): 386-394.
Iman, S., H. Metaq and Z. Sura. 2016. Formulation and in-vitro
evaluation of fast dissolving tablets of meloxicam solid
dispersion. Int. J. Pharm. Sci. Rev. Res. 41(1): 202-207.
Inayat, B., R. Prakash and K. Pritish. 2013. Formulation design and
optimization of novel mouth dissolving tablets for venlafaxine
hydrochloride using sublimation technique. J. Pharm. Res.
: 593-598.
Jagtap, R. and S. Mohite. 2019. Meloxicam-pectin--cyclodextrin
ternary complex by kneading for enhancement of solubility and
dissolution rate. Asian J. Pharm. Clin. Res. 12(4): 189-194.
Jain, J., H. Bhavna, R. Mittal and P. Mandev. 2011. Formulation and
evaluation of indomethacin bilayer sustained release tablets. Int.
J. PharmTech. Res. 3(2): 1132-1138.
Kapadiya, N., I. Singhvi, K. Mehta, G. Karwani and J. Dhrubo.
Hydrotropy: A promising tool for solubility enhancement:
A review. Int. J. Drug Dev. Res. 3(2): 26-33.
Karthik, N., B. Vijaya and V. Sateesh. 2013. Different techniques to
enhance the dissolution rate of Lovastatin: Formulation and
evaluation. Asian J. Pharm. Clin. Res. 6(1): 56-60.
Kulkarni, S. V., R. P., Kumar, N. Patel, S. B. Rao, B. Ramesh
and A. P. Kumar. 2011. Formulation and evaluation of fast
disintigrating meloxicam tablets and its comparison with
marketed product. Int. J. Pharm. Pharm. Sci. 3(1): 9193.
Mahavir, C., C. Atika, S. Anil, G. Saurabh and M. Shaily. 2012. New
quantitative estimation of acetazolamide bulk sample using
hydrotropic solubilizing agents. World J. Pharm. Res. 1(1):
-57.
Malvey, S., N. Kshirasagar, V. Vishnu and J. Srikanth. 2015.
Formulation and evaluation of acyclovir orodispersible tablets
using sublimation method. J. Gen. Pract. 3(4): e1000208.
Margret, R., B. Debjit, Y. Rahul, B. Jayakar and K. Sampath. 2012.
Formulation and evaluation the oral tablets ibuprofen. Pharm.
Innov. 1(9): 32-43.
Mohamed, E., S. Mustafa, N. Aly and I. Assem. 2017. In vitro and
in vivo evaluation of tablets containing meloxicam PEG 6000
ball-milled Co-ground mixture. J. Appl. Pharm. Sci. 7(3): 31-39.
Nabeela, S. and Z. Shahiq. 2018. Development of fast dissolving
tablets of flurbiprofen by sublimation method and its in vitro
evaluation development of fast dissolving tablets of flurbiprofen
by sublimation method and its in vitro evaluation. Braz. J. Pharm.
Sci. 54(4): e17061.
Nabeela, S. and Z. Shahiq. 2018. Development of fast dissolving
tablets of flurbiprofen by sublimation method and its in vitro
evaluation. Braz. J. Pharm. Sci. 54(4): e17061.
Narayan, K. 2018. Technologies to improve the solubility, dissolution
and bioavailability of poorly soluble drugs. J. Anal. Pharm. Res.
(1): e00198.
Ngwuluka, N., B. Idiakhoa, E. Nep, I. Ogaji and I. Okafor. 2010.
Formulation and evaluation of paracetamol tablets manufactured
using the dried fruit of Phoenix dactylifera Linn as an excipient.
Res. Pharm. Biotech. 2(3): 25-32.
Pawan, S., Prevesh, K. and P. Neelkant. 2017. Formulation and
evaluation of aspirin tablets by using different lubricants in
combination for better kinetic drug release study by PCP. Res. J.
Pharm. Technol. 10(9): 2934-2938.
Phuong, T., P. Yong-Chul, K. Dong-Hyun, L. Sang-Eun, K. Jin-Ki and
P. Jeong-Sook. 2019. Overview of the manufacturing methods
of solid dispersion technology for improving the solubility of
poorly water-soluble drugs and application to anticancer drugs.
Pharmaceutics. 11(3): 132.
Ravi, K., S. Palanichamy, M. Rajesh, R. Godwin, V. Anusha, N.
Parasakthi and A. Thanga. 2010. Formulation and evaluation
of orodispersible piroxicam tablets. J. Pharm. Sci. Res. 2(10):
-621.
Shoormeij, Z., A. Taheri and A. Homayouni. 2018. Preparation andphysicochemical characterization of meloxicam orally fast
disintegration tablet using its solid dispersion. Braz. J. Pharm.
(4): 176.
USP. 2008. The United States Pharmacopea. p2110-2114.
Varun, R., L. Venkateshwarlu and L. Srikanth. 2010. Solubility
enhancement techniques. Int. J. Pharm. Sci. Rev. Res. 5(1):
-51.
Yellela, S. 2010. Pharmaceutical technologies for enhancing oral
bioavailability of poorly soluble drugs. J. Bioequivalence
Bioavailab. 2(2): 28-36.
Zahra, S., T. Azade and H. Alireza. 2017. Preparation and
physicochemical characterization of meloxicam orally fast
disintegration tablet using its solid dispersion. Braz. J. Pharm.
Sci. 53(4): e00176.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Hemn L. Qader, Tara A. Abdula, Huner K. Omer
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).